Momordicine-I suppresses head and neck cancer growth by modulating key metabolic pathways

Abstract One of the hallmarks of cancer is metabolic reprogramming which controls cellular homeostasis and therapy resistance. Here, we investigated the effect of momordicine-I (M-I), a key bioactive compound from Momordica charantia (bitter melon), on metabolic pathways in human head and neck cance...

Full description

Saved in:
Bibliographic Details
Main Authors: Debojyoty Bandyopadhyay, Ellen T. Tran, Ruchi A. Patel, Matthew A. Luetzen, Kevin Cho, Leah P. Shriver, Gary J. Patti, Mark A. Varvares, David A. Ford, Kyle S. McCommis, Ratna B. Ray
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Cell Communication and Signaling
Subjects:
Online Access:https://doi.org/10.1186/s12964-024-01951-w
Tags: Add Tag
No Tags, Be the first to tag this record!